SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-210679
Filing Date
2023-08-11
Accepted
2023-08-11 16:01:00
Documents
18
Period of Report
2023-08-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d518652d8k.htm   iXBRL 8-K 47299
2 EX-1.1 d518652dex11.htm EX-1.1 179647
3 EX-4.1 d518652dex41.htm EX-4.1 85867
4 EX-4.2 d518652dex42.htm EX-4.2 87771
5 EX-4.3 d518652dex43.htm EX-4.3 100925
6 EX-99.1 d518652dex991.htm EX-99.1 8791
7 EX-99.2 d518652dex992.htm EX-99.2 8560
  Complete submission text file 0001193125-23-210679.txt   777850

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA bntc-20230808.xsd EX-101.SCH 2887
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bntc-20230808_lab.xml EX-101.LAB 17236
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bntc-20230808_pre.xml EX-101.PRE 10837
12 EXTRACTED XBRL INSTANCE DOCUMENT d518652d8k_htm.xml XML 3212
Mailing Address 3940 TRUST WAY HAYWARD CA 94545
Business Address 3940 TRUST WAY HAYWARD CA 94545 (510) 780-0819
Benitec Biopharma Inc. (Filer) CIK: 0001808898 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39267 | Film No.: 231163867
SIC: 2834 Pharmaceutical Preparations